- Published on
Emergency And Acute Medicine - Granulocytopenia
Basics Description
Granulocytopenia is a significant reduction in circulating granulocytes in peripheral blood. The three granulocyte classes are neutrophils (polymorphonuclear cells and bands), eosinophils, and basophils. Because neutrophils predominate, granulocytopenia is commonly used interchangeably with neutropenia. Granulocytes are essential components of innate immunity.
Clinical risk is best assessed by the absolute neutrophil count (ANC), calculated as WBC × (% PMNs + bands). Modern analyzers typically report ANC automatically. Neutropenia is defined as ANC <1,500 cells />m³: mild (1,000–1,500), moderate (500–1,000), severe (<500). agranulocytosis refers to anc <100. patients with rapidly falling counts are at higher infection risk than those low but recovering counts. myelodysplastic syndromes may be functionally granulocytopenic due impaired neutrophil function.< />pan>
Four mechanisms lead to granulocytopenia: decreased production, ineffective granulopoiesis, margination of neutrophils to the vascular endothelium, and increased peripheral destruction. Untreated febrile neutropenia carries mortality rates up to 50%, closely related to severity, duration, and delay to antibiotic therapy. Approximately 21% of oncology patients with neutropenic fever develop serious complications.
Pediatric considerations include physiologically elevated neonatal ANC during the first days of life and lower infection risk in otherwise healthy children older than 3 months with isolated moderate neutropenia.
Etiology
The most common cause is myelosuppressive chemotherapy or radiation, typically occurring 5–10 days after treatment. Drug-induced granulocytopenia is the second most common cause and usually requires at least 4 weeks of exposure, resolving within 30 days of discontinuation. High-risk drugs include clozapine, sulfasalazine, thioamides, antiplatelet agents, antiepileptics, NSAIDs, methotrexate, cyclophosphamide, colchicine, azathioprine, and ganciclovir.
Infectious causes include bacterial (typhoid, Shigella, brucellosis, tularemia, tuberculosis), parasitic (malaria, kala-azar), rickettsial (ehrlichiosis, RMSF), and viral infections, particularly HIV, hepatitis B, and EBV.
Immune-mediated causes include primary immune neutropenia, autoimmune diseases, thymoma, complement activation, transfusion reactions, alcoholism, nutritional deficiencies (vitamin B12, folate, copper), chronic idiopathic neutropenia, and pure white cell aplasia. Numerous congenital causes exist in pediatric populations.
Diagnosis Signs And Symptoms
Patients may present with fever or subtle signs of bacterial or fungal infection. Symptoms of pancytopenia include fatigue, pallor, petechiae, epistaxis, and spontaneous bleeding. Medication history, prior ANC values, and family history are essential. Patients should be questioned carefully about systemic and localizing symptoms of infection.
Physical examination focuses on identifying infection, including careful oral, pulmonary, abdominal, skin, catheter site, and perirectal assessment. Rectal examination is relatively contraindicated until antibiotics are initiated.
Essential Workup
A complete physical examination with emphasis on oral mucosa, perianal region, skin, lungs, and abdomen is required. Rectal examination may be performed after initiation of antibiotics if clinically indicated.
Diagnosis Tests And Interpretation
CBC with differential to determine ANC is mandatory. Additional studies include liver function tests, blood cultures from two sites (including catheter if present), urinalysis and urine culture, sputum or stool cultures when indicated, and CSF analysis if neurologic symptoms are present. Chest radiography should be obtained even in the absence of respiratory findings.
Differential Diagnosis
Laboratory error, malignancy, chemotherapy effects, medication reactions, infections, autoimmune disease, genetic conditions, transfusion reactions, nutritional deficiencies, tumor lysis syndrome, and hypersplenism. Some African American patients may have a normal baseline ANC around 1,000 cells/mm³.
Treatment Initial Stabilization Therapy
Patients in shock require immediate resuscitation with 1 L of 0.9% NS (pediatrics: 20 mL/kg), vasopressors if needed, and early goal-directed therapy when appropriate.
Ed Treatment Procedures
Initiate protective isolation when possible. After cultures are obtained, administer empiric broad-spectrum antibiotics promptly for suspected infection. Appropriate regimens include cefepime, ceftazidime (with or without an aminoglycoside), imipenem/cilastatin, fluoroquinolones, or an aminoglycoside combined with an antipseudomonal β-lactam. Vancomycin should be added when MRSA risk is present.
Medication
Common agents include cefepime, ceftazidime, imipenem/cilastatin, levofloxacin, aminoglycosides, mezlocillin, and vancomycin. Dosing should be adjusted for renal function and patient age.
Follow-Up Disposition
Admission is indicated for any signs of infection, unreliable follow-up, or inability to ensure close monitoring. Selected asymptomatic patients with known chronic granulocytopenia and reliable follow-up may be discharged.
Issues For Referral
All patients with granulocytopenia should be referred to their primary physician or a hematologist.
Follow-Up Recommendations
Patients should return immediately for fever or new symptoms and follow up within 48 hours with their physician.
Key Clinical Insights And Frequent Errors
Infections may present subtly or without classic signs due to impaired inflammatory response. Rectal exams and rectal temperatures should be avoided until antibiotics are started to reduce the risk of perirectal abscess and bacteremia. Febrile patients with ANC <500 require immediate aggressive management with iv fluids and broad-spectrum antibiotics. hepatosplenic candidiasis may emerge during neutrophil recovery presents abscess formation, requiring antifungal therapy such as amphotericin b.< />pan>
Basics Description
Granulocytopenia is a significant reduction in circulating granulocytes in peripheral blood. The three granulocyte classes are neutrophils (polymorphonuclear cells and bands), eosinophils, and basophils. Because neutrophils predominate, granulocytopenia is commonly used interchangeably with neutropenia. Granulocytes are essential components of innate immunity.
Clinical risk is best assessed by the absolute neutrophil count (ANC), calculated as WBC × (% PMNs + bands). Modern analyzers typically report ANC automatically. Neutropenia is defined as ANC <1,500 cells />m³: mild (1,000–1,500), moderate (500–1,000), severe (<500). agranulocytosis refers to anc <100. patients with rapidly falling counts are at higher infection risk than those low but recovering counts. myelodysplastic syndromes may be functionally granulocytopenic due impaired neutrophil function.< />pan>
Four mechanisms lead to granulocytopenia: decreased production, ineffective granulopoiesis, margination of neutrophils to the vascular endothelium, and increased peripheral destruction. Untreated febrile neutropenia carries mortality rates up to 50%, closely related to severity, duration, and delay to antibiotic therapy. Approximately 21% of oncology patients with neutropenic fever develop serious complications.
Pediatric considerations include physiologically elevated neonatal ANC during the first days of life and lower infection risk in otherwise healthy children older than 3 months with isolated moderate neutropenia.
Etiology
The most common cause is myelosuppressive chemotherapy or radiation, typically occurring 5–10 days after treatment. Drug-induced granulocytopenia is the second most common cause and usually requires at least 4 weeks of exposure, resolving within 30 days of discontinuation. High-risk drugs include clozapine, sulfasalazine, thioamides, antiplatelet agents, antiepileptics, NSAIDs, methotrexate, cyclophosphamide, colchicine, azathioprine, and ganciclovir.
Infectious causes include bacterial (typhoid, Shigella, brucellosis, tularemia, tuberculosis), parasitic (malaria, kala-azar), rickettsial (ehrlichiosis, RMSF), and viral infections, particularly HIV, hepatitis B, and EBV.
Immune-mediated causes include primary immune neutropenia, autoimmune diseases, thymoma, complement activation, transfusion reactions, alcoholism, nutritional deficiencies (vitamin B12, folate, copper), chronic idiopathic neutropenia, and pure white cell aplasia. Numerous congenital causes exist in pediatric populations.
Diagnosis Signs And Symptoms
Patients may present with fever or subtle signs of bacterial or fungal infection. Symptoms of pancytopenia include fatigue, pallor, petechiae, epistaxis, and spontaneous bleeding. Medication history, prior ANC values, and family history are essential. Patients should be questioned carefully about systemic and localizing symptoms of infection.
Physical examination focuses on identifying infection, including careful oral, pulmonary, abdominal, skin, catheter site, and perirectal assessment. Rectal examination is relatively contraindicated until antibiotics are initiated.
Essential Workup
A complete physical examination with emphasis on oral mucosa, perianal region, skin, lungs, and abdomen is required. Rectal examination may be performed after initiation of antibiotics if clinically indicated.
Diagnosis Tests And Interpretation
CBC with differential to determine ANC is mandatory. Additional studies include liver function tests, blood cultures from two sites (including catheter if present), urinalysis and urine culture, sputum or stool cultures when indicated, and CSF analysis if neurologic symptoms are present. Chest radiography should be obtained even in the absence of respiratory findings.
Differential Diagnosis
Laboratory error, malignancy, chemotherapy effects, medication reactions, infections, autoimmune disease, genetic conditions, transfusion reactions, nutritional deficiencies, tumor lysis syndrome, and hypersplenism. Some African American patients may have a normal baseline ANC around 1,000 cells/mm³.
Treatment Initial Stabilization Therapy
Patients in shock require immediate resuscitation with 1 L of 0.9% NS (pediatrics: 20 mL/kg), vasopressors if needed, and early goal-directed therapy when appropriate.
Ed Treatment Procedures
Initiate protective isolation when possible. After cultures are obtained, administer empiric broad-spectrum antibiotics promptly for suspected infection. Appropriate regimens include cefepime, ceftazidime (with or without an aminoglycoside), imipenem/cilastatin, fluoroquinolones, or an aminoglycoside combined with an antipseudomonal β-lactam. Vancomycin should be added when MRSA risk is present.
Medication
Common agents include cefepime, ceftazidime, imipenem/cilastatin, levofloxacin, aminoglycosides, mezlocillin, and vancomycin. Dosing should be adjusted for renal function and patient age.
Follow-Up Disposition
Admission is indicated for any signs of infection, unreliable follow-up, or inability to ensure close monitoring. Selected asymptomatic patients with known chronic granulocytopenia and reliable follow-up may be discharged.
Issues For Referral
All patients with granulocytopenia should be referred to their primary physician or a hematologist.
Follow-Up Recommendations
Patients should return immediately for fever or new symptoms and follow up within 48 hours with their physician.
Key Clinical Insights And Frequent Errors
Infections may present subtly or without classic signs due to impaired inflammatory response. Rectal exams and rectal temperatures should be avoided until antibiotics are started to reduce the risk of perirectal abscess and bacteremia. Febrile patients with ANC <500 require immediate aggressive management with iv fluids and broad-spectrum antibiotics. hepatosplenic candidiasis may emerge during neutrophil recovery presents abscess formation, requiring antifungal therapy such as amphotericin b.< />pan>
0 Comments
